Six Months Before His Death Presley Gerber Spoke Candidly About Controversial Psychedelic Addiction Treatment

Presley Gerber: Personal Struggles and Public Openness

Presley Gerber, aged 27 and the son of Cindy Crawford and Rande Gerber, passed away on September 20, 2026. The circumstances of his death have sparked both sadness and curiosity, particularly because Presley had been a vocal advocate for mental health awareness and unconventional treatment methods. At the time of his passing, he was receiving care at a rehabilitation facility, Resolutions Living, highlighting his ongoing battle with addiction and mental health challenges.

The Los Angeles County Medical Examiner confirmed that Presley’s death occurred at 09:45 AM on September 20, following the response of local paramedics. While the Santa Monica Police Department is investigating, authorities indicated there was no immediate evidence of foul play. The final cause and manner of death remain pending, as the medical examiner continues its review. Suspected overdose has been cited as a potential factor, although official results are still being awaited.

Through his personal and social media platforms, Presley Gerber consistently shared his experiences with depression, substance abuse, and efforts at recovery. In an Instagram video from 2025, he described his mental health struggles as “really bad” and emphasized his desire to surround himself with positive influences. His aim was to reach others facing similar difficulties, offering hope through candid self-reflection.

Psychedelic Treatments: Gerber’s Experience with Ibogaine

In March 2026, Presley Gerber documented part of his journey with a controversial psychedelic treatment known as ibogaine. The video, filmed in Cancun, Mexico, showed Presley undergoing a ritual-like session in preparation for the therapy, accompanied by supportive staff and friends.

He described his emotions before the treatment as “absolutely terrified,” but expressed a determination to trust the process and address the issues he had been battling. He wrote, “My mantras were love yourself and lis gotta be the last time for this reason. Letting go of control didn’t come easy, but I trusted there was something bigger than me guiding it.” Presley detailed how facing realities he had long avoided was a significant step towards personal healing. He also noted the compassion and professionalism of the clinic’s staff, stating that their support helped him through difficult moments and enabled him to make “dope a** friends there.”

What Is Ibogaine?

Ibogaine is a naturally-occurring psychoactive compound extracted from the root bark of the African shrub Tabernanthe iboga. Its use in indigenous African cultures dates back centuries, where it served ceremonial and spiritual purposes. In recent decades, interest in ibogaine has expanded as researchers and practitioners explore its potential benefits for treating opioid addiction and other mental health disorders including severe depression, anxiety, and post-traumatic stress disorder (PTSD).

Ibogaine is known to interact with a variety of neural pathways, producing psychedelic effects and reported reductions in substance cravings. Clinical experiences largely suggest its effects are intense and can last several hours, involving pronounced introspection and potentially transformative insights. However, medical organizations in the United States have not licensed ibogaine for addiction treatment, citing concerns about safety, efficacy, and regulatory standards. Nevertheless, treatments are available in alternative clinics across other countries, including Mexico, Costa Rica, and South Africa.

Ibogaine Clinics: Accessibility and Controversies

The Beond Ibogaine clinic in Cancun is among the internationally recognized centers offering ibogaine-assisted therapy. Reports indicate that treatment programs can begin at $12,500 for a ten-day session, drawing clients worldwide who seek alternatives to traditional addiction models. The clinics typically feature multidisciplinary staff including medical professionals, therapists, and spiritual facilitators. Clients often undergo thorough pre-treatment screening to reduce risks and ensure appropriate support during the procedure.

Beneath the promise of ibogaine’s transformative powers, controversies persist. The lack of regulatory approval in the United States reflects ongoing debates about the treatment’s safety profile. Ibogaine’s powerful psychoactive effects can be accompanied by serious cardiovascular risks, especially among individuals with underlying health conditions. According to the World Health Organization and leading addiction experts, research into ibogaine’s safety and efficacy remains incomplete, with more controlled studies needed to measure long-term outcomes. Nevertheless, anecdotal evidence, including testimonies from individuals like Presley Gerber, continue to drive interest and support further investigation.

Substance Abuse Recovery: Evolving Treatment Approaches

The landscape of addiction treatment has evolved considerably in recent years. Traditional approaches, such as 12-step programs, cognitive behavioral therapy, and medication-assisted treatments (e.g., methadone or buprenorphine for opioid addiction), remain staples in clinical practice. However, mounting interest in alternative therapies—including psychedelic-assisted interventions—highlights a broader push toward individualized care.

In 2019, the United States Food and Drug Administration granted breakthrough therapy status to psilocybin-assisted therapy for depression and MDMA-assisted therapy for PTSD, based on promising clinical trials. These developments indicate growing openness toward integrating psychedelic compounds within mainstream treatment protocols, though regulatory approval and insurance coverage remain obstacles.

Ibogaine’s position within this landscape is unique. Its roots in traditional medicine, intense physiological effects, and legal status as a Schedule I substance in the US present significant barriers. Nonetheless, global interest in psychedelic-assisted addiction therapies reflects societal shifts toward reevaluating historical stigmas and exploring holistic healing options.

Expert Views on Psychedelic-Assisted Therapy

Leading experts highlight both the potential and the uncertainties surrounding ibogaine and similar compounds. Dr. Matthew Johnson, Professor of Psychiatry and Behavioral Sciences at Johns Hopkins University, points out, “Psychedelic therapies represent a groundbreaking paradigm, but rigorous safety protocols and scientific validation are essential before widespread adoption.” According to the Mayo Clinic, while initial results for psychedelic-assisted therapy are promising, “More research is necessary to understand safety, efficacy, and long-term impacts.”

Researchers also contend with the ethical complexities of offering treatments outside formal regulatory oversight. Although facilities in Mexico and other countries provide an option for individuals seeking alternatives, international standards vary and may differ significantly from US medical norms. This introduces questions about patient safety, informed consent, and clinical follow-up.

Public and International Reactions

Society’s response to Presley Gerber’s openness, as well as his tragic passing, has been shaped by broader conversations about mental health, addiction, and the search for healing. Celebrities and public figures—including family friends like Paris Hilton—have expressed condolences and underlined the importance of supporting those struggling with addiction.

Presley’s willingness to share his story fostered dialogue about the realities of recovery and the risks associated with substance abuse. As the investigation into his death continues, advocates for psychedelic-assisted therapies emphasize the need for research, accessible care, and stigma reduction—especially in light of rising rates of overdose and addiction-related health challenges in the US and globally.

The Importance of Mental Health Advocacy

Presley Gerber’s efforts to engage with his followers through social media challenged stereotypes about addiction and recovery, while encouraging individuals to seek positive support systems. Mental health organizations, such as the National Alliance on Mental Illness (NAMI), emphasize that sharing personal stories can help others feel less isolated and prompt societal action to increase funding, resources, and educational campaigns.

The legacy of Presley Gerber is entwined with his courage in discussing mental health and addiction—a reminder of the importance of compassion and understanding amid ongoing challenges. While his journey included controversial approaches and personal struggles, it served to illuminate the complexities of seeking recovery and the necessity of continued innovation in mental health care.

Conclusion

The candidness displayed by Presley Gerber regarding his experience with ibogaine, and his broader battle with addiction, underscores the evolving nature of substance abuse treatment. As society moves toward greater acceptance and research of psychedelic-assisted therapies, the balance between innovation and safety remains paramount. Gerber’s openness and the attention to his story reinforce the message that addiction is a multifaceted challenge—one that requires empathy, evidence-based support, and ongoing dialogue.

Sources

• Reuters
• BBC
• The Guardian
• World Health Organization (WHO)
• Centers for Disease Control and Prevention (CDC)
• Mayo Clinic
• PEOPLE
• Page Six
• Newsner

Disclaimer: This content is intended for entertainment purposes only and is not based on real events.